Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Blood transfusion diagnostics industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Product trends
2.5 Application trends
2.6 End-use trends
Chapter 3 Blood Transfusion Diagnostics Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of chronic diseases and blood related disorders
3.2.1.2 Rising number of road & trauma accident cases and organ transplant surgeries
3.2.1.3 Growing initiatives for blood donation campaigns
3.2.1.4 Increasing demand for blood and blood components
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of sufficient blood donations as compared to demand
3.2.2.2 High cost of instruments
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By application
3.3.3 By end use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Pricing analysis, 2022
3.7 Reimbursement scenario
3.8 Technology landscape
3.9 Future market trends
3.10 GAP analysis
3.11 Porter's analysis
3.12 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Blood Transfusion Diagnostics Market Size and Forecast, By Product (USD Million & Units)
5.1 Key trends, by product
5.2 Instruments
5.3 Reagents & Kits
Chapter 6 Blood Transfusion Diagnostics Market Size and Forecast, By Application (USD Million)
6.1 Key trends, by application
6.2 Blood grouping
6.3 Disease screening
6.3.1 Serological disease screening
6.3.2 Molecular disease screening
Chapter 7 Blood Transfusion Diagnostics Market Size and Forecast, By End-use (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Diagnostic laboratories
7.4 Blood banks
7.5 Others
Chapter 8 Blood Transfusion Diagnostics Market Size and Forecast, By Region (USD Million & Units)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Austria
8.3.7 Poland
8.3.8 Belgium
8.3.9 The Netherlands
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Indonesia
8.4.7 Philippines
8.4.8 Malaysia
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Columbia
8.5.5 Chile
8.5.6 Peru
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Israel
8.6.5 Turkey
8.6.6 Egypt
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 BAG Healthcare GmBH
9.3 Bio-Rad Laboratories, Inc
9.4 Danaher
9.5 Diagnostica Stago
9.6 DiaSorin S.p.A.
9.7 F. Hoffmann-La Roche Ltd
9.8 Grifols S.A.
9.9 Hologic, Inc.
9.10 Immucor Inc.
9.11 Merck KGaA
9.12 Ortho Clinical Diagnostics
9.13 Quotient Ltd
9.14 Thermo Fisher Scientific Inc.
